nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—Tachycardia—Mitoxantrone—multiple sclerosis	0.00179	0.00219	CcSEcCtD
Glycopyrrolate—Skin disorder—Mitoxantrone—multiple sclerosis	0.00178	0.00218	CcSEcCtD
Glycopyrrolate—Irritability—Methotrexate—multiple sclerosis	0.00177	0.00217	CcSEcCtD
Glycopyrrolate—Vomiting—Cladribine—multiple sclerosis	0.00177	0.00217	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00177	0.00217	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Prednisone—multiple sclerosis	0.00177	0.00217	CcSEcCtD
Glycopyrrolate—Mood swings—Methotrexate—multiple sclerosis	0.00176	0.00216	CcSEcCtD
Glycopyrrolate—Rash—Cladribine—multiple sclerosis	0.00176	0.00216	CcSEcCtD
Glycopyrrolate—Dermatitis—Cladribine—multiple sclerosis	0.00176	0.00215	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.00175	0.00215	CcSEcCtD
Glycopyrrolate—Headache—Cladribine—multiple sclerosis	0.00175	0.00214	CcSEcCtD
Glycopyrrolate—Vision blurred—Prednisolone—multiple sclerosis	0.00174	0.00213	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Prednisone—multiple sclerosis	0.00173	0.00212	CcSEcCtD
Glycopyrrolate—Hypotension—Mitoxantrone—multiple sclerosis	0.00171	0.0021	CcSEcCtD
Glycopyrrolate—Mental disorder—Methylprednisolone—multiple sclerosis	0.0017	0.00209	CcSEcCtD
Glycopyrrolate—Erythema—Triamcinolone—multiple sclerosis	0.00169	0.00208	CcSEcCtD
Glycopyrrolate—Malnutrition—Methylprednisolone—multiple sclerosis	0.00169	0.00207	CcSEcCtD
Glycopyrrolate—Erythema—Methylprednisolone—multiple sclerosis	0.00169	0.00207	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Azathioprine—multiple sclerosis	0.00167	0.00205	CcSEcCtD
Glycopyrrolate—Dysgeusia—Triamcinolone—multiple sclerosis	0.00166	0.00203	CcSEcCtD
Glycopyrrolate—Nausea—Cladribine—multiple sclerosis	0.00166	0.00203	CcSEcCtD
Glycopyrrolate—Somnolence—Mitoxantrone—multiple sclerosis	0.00163	0.002	CcSEcCtD
Glycopyrrolate—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00161	0.00198	CcSEcCtD
Glycopyrrolate—Convulsion—Prednisolone—multiple sclerosis	0.0016	0.00196	CcSEcCtD
Glycopyrrolate—Hypertension—Prednisolone—multiple sclerosis	0.00159	0.00195	CcSEcCtD
Glycopyrrolate—Fatigue—Mitoxantrone—multiple sclerosis	0.00158	0.00194	CcSEcCtD
Glycopyrrolate—Pain—Mitoxantrone—multiple sclerosis	0.00157	0.00192	CcSEcCtD
Glycopyrrolate—Constipation—Mitoxantrone—multiple sclerosis	0.00157	0.00192	CcSEcCtD
Glycopyrrolate—Abdominal discomfort—Methotrexate—multiple sclerosis	0.00154	0.00189	CcSEcCtD
Glycopyrrolate—Erythema—Betamethasone—multiple sclerosis	0.00154	0.00188	CcSEcCtD
Glycopyrrolate—Erythema—Dexamethasone—multiple sclerosis	0.00154	0.00188	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Prednisone—multiple sclerosis	0.00151	0.00185	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00151	0.00185	CcSEcCtD
Glycopyrrolate—Oedema—Prednisolone—multiple sclerosis	0.0015	0.00184	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Prednisolone—multiple sclerosis	0.0015	0.00184	CcSEcCtD
Glycopyrrolate—Dysuria—Methotrexate—multiple sclerosis	0.0015	0.00184	CcSEcCtD
Glycopyrrolate—Dizziness—Azathioprine—multiple sclerosis	0.0015	0.00184	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.0015	0.00184	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.00149	0.00183	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Methotrexate—multiple sclerosis	0.00148	0.00181	CcSEcCtD
Glycopyrrolate—Convulsion—Triamcinolone—multiple sclerosis	0.00147	0.0018	CcSEcCtD
Glycopyrrolate—Tachycardia—Prednisolone—multiple sclerosis	0.00147	0.0018	CcSEcCtD
Glycopyrrolate—Convulsion—Methylprednisolone—multiple sclerosis	0.00146	0.0018	CcSEcCtD
Glycopyrrolate—Hypertension—Triamcinolone—multiple sclerosis	0.00146	0.00179	CcSEcCtD
Glycopyrrolate—Hypertension—Methylprednisolone—multiple sclerosis	0.00146	0.00179	CcSEcCtD
Glycopyrrolate—Urticaria—Mitoxantrone—multiple sclerosis	0.00146	0.00178	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00145	0.00178	CcSEcCtD
Glycopyrrolate—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00145	0.00178	CcSEcCtD
Glycopyrrolate—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00145	0.00178	CcSEcCtD
Glycopyrrolate—Vomiting—Azathioprine—multiple sclerosis	0.00144	0.00177	CcSEcCtD
Glycopyrrolate—Pneumonia—Methotrexate—multiple sclerosis	0.00144	0.00177	CcSEcCtD
Glycopyrrolate—Infestation NOS—Methotrexate—multiple sclerosis	0.00143	0.00176	CcSEcCtD
Glycopyrrolate—Infestation—Methotrexate—multiple sclerosis	0.00143	0.00176	CcSEcCtD
Glycopyrrolate—Drowsiness—Methotrexate—multiple sclerosis	0.00143	0.00176	CcSEcCtD
Glycopyrrolate—Rash—Azathioprine—multiple sclerosis	0.00143	0.00175	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00143	0.00175	CcSEcCtD
Glycopyrrolate—Dermatitis—Azathioprine—multiple sclerosis	0.00143	0.00175	CcSEcCtD
Glycopyrrolate—Flushing—Prednisone—multiple sclerosis	0.00143	0.00175	CcSEcCtD
Glycopyrrolate—Headache—Azathioprine—multiple sclerosis	0.00142	0.00174	CcSEcCtD
Glycopyrrolate—Dry mouth—Triamcinolone—multiple sclerosis	0.00141	0.00173	CcSEcCtD
Glycopyrrolate—Confusional state—Methylprednisolone—multiple sclerosis	0.00139	0.00171	CcSEcCtD
Glycopyrrolate—Oedema—Triamcinolone—multiple sclerosis	0.00138	0.0017	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00138	0.0017	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00138	0.00169	CcSEcCtD
Glycopyrrolate—Infection—Triamcinolone—multiple sclerosis	0.00137	0.00168	CcSEcCtD
Glycopyrrolate—Sweating—Methotrexate—multiple sclerosis	0.00137	0.00168	CcSEcCtD
Glycopyrrolate—Infection—Methylprednisolone—multiple sclerosis	0.00137	0.00168	CcSEcCtD
Glycopyrrolate—Insomnia—Prednisolone—multiple sclerosis	0.00136	0.00167	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00135	0.00166	CcSEcCtD
Glycopyrrolate—Epistaxis—Methotrexate—multiple sclerosis	0.00135	0.00166	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00135	0.00166	CcSEcCtD
Glycopyrrolate—Tachycardia—Triamcinolone—multiple sclerosis	0.00135	0.00165	CcSEcCtD
Glycopyrrolate—Mental disorder—Prednisone—multiple sclerosis	0.00135	0.00165	CcSEcCtD
Glycopyrrolate—Nausea—Azathioprine—multiple sclerosis	0.00135	0.00165	CcSEcCtD
Glycopyrrolate—Tachycardia—Methylprednisolone—multiple sclerosis	0.00135	0.00165	CcSEcCtD
Glycopyrrolate—Skin disorder—Methylprednisolone—multiple sclerosis	0.00134	0.00164	CcSEcCtD
Glycopyrrolate—Malnutrition—Prednisone—multiple sclerosis	0.00134	0.00164	CcSEcCtD
Glycopyrrolate—Erythema—Prednisone—multiple sclerosis	0.00134	0.00164	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00134	0.00164	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00133	0.00164	CcSEcCtD
Glycopyrrolate—Convulsion—Betamethasone—multiple sclerosis	0.00133	0.00163	CcSEcCtD
Glycopyrrolate—Convulsion—Dexamethasone—multiple sclerosis	0.00133	0.00163	CcSEcCtD
Glycopyrrolate—Hypertension—Dexamethasone—multiple sclerosis	0.00133	0.00163	CcSEcCtD
Glycopyrrolate—Hypertension—Betamethasone—multiple sclerosis	0.00133	0.00163	CcSEcCtD
Glycopyrrolate—Asthenia—Mitoxantrone—multiple sclerosis	0.00131	0.00161	CcSEcCtD
Glycopyrrolate—Hypotension—Methylprednisolone—multiple sclerosis	0.00129	0.00158	CcSEcCtD
Glycopyrrolate—Pain—Prednisolone—multiple sclerosis	0.00129	0.00158	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Methotrexate—multiple sclerosis	0.00127	0.00156	CcSEcCtD
Glycopyrrolate—Vision blurred—Prednisone—multiple sclerosis	0.00126	0.00155	CcSEcCtD
Glycopyrrolate—Urethral disorder—Methotrexate—multiple sclerosis	0.00126	0.00154	CcSEcCtD
Glycopyrrolate—Oedema—Dexamethasone—multiple sclerosis	0.00125	0.00154	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00125	0.00154	CcSEcCtD
Glycopyrrolate—Oedema—Betamethasone—multiple sclerosis	0.00125	0.00154	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00125	0.00154	CcSEcCtD
Glycopyrrolate—Insomnia—Triamcinolone—multiple sclerosis	0.00125	0.00153	CcSEcCtD
Glycopyrrolate—Insomnia—Methylprednisolone—multiple sclerosis	0.00125	0.00153	CcSEcCtD
Glycopyrrolate—Infection—Betamethasone—multiple sclerosis	0.00125	0.00153	CcSEcCtD
Glycopyrrolate—Infection—Dexamethasone—multiple sclerosis	0.00125	0.00153	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Prednisolone—multiple sclerosis	0.00124	0.00152	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Betamethasone—multiple sclerosis	0.00123	0.00151	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00123	0.00151	CcSEcCtD
Glycopyrrolate—Agitation—Prednisone—multiple sclerosis	0.00123	0.00151	CcSEcCtD
Glycopyrrolate—Tachycardia—Betamethasone—multiple sclerosis	0.00122	0.0015	CcSEcCtD
Glycopyrrolate—Tachycardia—Dexamethasone—multiple sclerosis	0.00122	0.0015	CcSEcCtD
Glycopyrrolate—Dyspepsia—Triamcinolone—multiple sclerosis	0.00122	0.00149	CcSEcCtD
Glycopyrrolate—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00121	0.00149	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00121	0.00149	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00121	0.00149	CcSEcCtD
Glycopyrrolate—Urticaria—Prednisolone—multiple sclerosis	0.00119	0.00146	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Methotrexate—multiple sclerosis	0.00119	0.00146	CcSEcCtD
Glycopyrrolate—Fatigue—Triamcinolone—multiple sclerosis	0.00119	0.00146	CcSEcCtD
Glycopyrrolate—Fatigue—Methylprednisolone—multiple sclerosis	0.00119	0.00146	CcSEcCtD
Glycopyrrolate—Pain—Triamcinolone—multiple sclerosis	0.00118	0.00145	CcSEcCtD
Glycopyrrolate—Hypotension—Dexamethasone—multiple sclerosis	0.00117	0.00144	CcSEcCtD
Glycopyrrolate—Hypotension—Betamethasone—multiple sclerosis	0.00117	0.00144	CcSEcCtD
Glycopyrrolate—Vomiting—Mitoxantrone—multiple sclerosis	0.00117	0.00143	CcSEcCtD
Glycopyrrolate—Convulsion—Prednisone—multiple sclerosis	0.00116	0.00142	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Methotrexate—multiple sclerosis	0.00116	0.00142	CcSEcCtD
Glycopyrrolate—Hypertension—Prednisone—multiple sclerosis	0.00116	0.00142	CcSEcCtD
Glycopyrrolate—Rash—Mitoxantrone—multiple sclerosis	0.00116	0.00142	CcSEcCtD
Glycopyrrolate—Dermatitis—Mitoxantrone—multiple sclerosis	0.00115	0.00142	CcSEcCtD
Glycopyrrolate—Headache—Mitoxantrone—multiple sclerosis	0.00115	0.00141	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00114	0.0014	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00114	0.00139	CcSEcCtD
Glycopyrrolate—Insomnia—Betamethasone—multiple sclerosis	0.00113	0.00139	CcSEcCtD
Glycopyrrolate—Insomnia—Dexamethasone—multiple sclerosis	0.00113	0.00139	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00113	0.00139	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00113	0.00138	CcSEcCtD
Glycopyrrolate—Mental disorder—Methotrexate—multiple sclerosis	0.00113	0.00138	CcSEcCtD
Glycopyrrolate—Erythema—Methotrexate—multiple sclerosis	0.00112	0.00137	CcSEcCtD
Glycopyrrolate—Malnutrition—Methotrexate—multiple sclerosis	0.00112	0.00137	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Prednisolone—multiple sclerosis	0.00111	0.00136	CcSEcCtD
Glycopyrrolate—Dyspepsia—Dexamethasone—multiple sclerosis	0.0011	0.00135	CcSEcCtD
Glycopyrrolate—Dyspepsia—Betamethasone—multiple sclerosis	0.0011	0.00135	CcSEcCtD
Glycopyrrolate—Urticaria—Triamcinolone—multiple sclerosis	0.0011	0.00135	CcSEcCtD
Glycopyrrolate—Urticaria—Methylprednisolone—multiple sclerosis	0.0011	0.00134	CcSEcCtD
Glycopyrrolate—Dysgeusia—Methotrexate—multiple sclerosis	0.0011	0.00134	CcSEcCtD
Glycopyrrolate—Body temperature increased—Triamcinolone—multiple sclerosis	0.00109	0.00134	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Prednisone—multiple sclerosis	0.00109	0.00134	CcSEcCtD
Glycopyrrolate—Oedema—Prednisone—multiple sclerosis	0.00109	0.00134	CcSEcCtD
Glycopyrrolate—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00109	0.00134	CcSEcCtD
Glycopyrrolate—Nausea—Mitoxantrone—multiple sclerosis	0.00109	0.00133	CcSEcCtD
Glycopyrrolate—Infection—Prednisone—multiple sclerosis	0.00109	0.00133	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00108	0.00133	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00108	0.00133	CcSEcCtD
Glycopyrrolate—Fatigue—Dexamethasone—multiple sclerosis	0.00108	0.00133	CcSEcCtD
Glycopyrrolate—Fatigue—Betamethasone—multiple sclerosis	0.00108	0.00133	CcSEcCtD
Glycopyrrolate—Pain—Betamethasone—multiple sclerosis	0.00107	0.00132	CcSEcCtD
Glycopyrrolate—Pain—Dexamethasone—multiple sclerosis	0.00107	0.00132	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Prednisone—multiple sclerosis	0.00107	0.00131	CcSEcCtD
Glycopyrrolate—Tachycardia—Prednisone—multiple sclerosis	0.00107	0.00131	CcSEcCtD
Glycopyrrolate—Skin disorder—Prednisone—multiple sclerosis	0.00106	0.0013	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Prednisone—multiple sclerosis	0.00106	0.00129	CcSEcCtD
Glycopyrrolate—Vision blurred—Methotrexate—multiple sclerosis	0.00105	0.00129	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Betamethasone—multiple sclerosis	0.00103	0.00127	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00103	0.00127	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00103	0.00126	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00103	0.00126	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00102	0.00125	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00102	0.00125	CcSEcCtD
Glycopyrrolate—Urticaria—Dexamethasone—multiple sclerosis	0.000997	0.00122	CcSEcCtD
Glycopyrrolate—Urticaria—Betamethasone—multiple sclerosis	0.000997	0.00122	CcSEcCtD
Glycopyrrolate—Dizziness—Prednisolone—multiple sclerosis	0.000994	0.00122	CcSEcCtD
Glycopyrrolate—Asthenia—Triamcinolone—multiple sclerosis	0.000992	0.00122	CcSEcCtD
Glycopyrrolate—Body temperature increased—Betamethasone—multiple sclerosis	0.000992	0.00122	CcSEcCtD
Glycopyrrolate—Abdominal pain—Betamethasone—multiple sclerosis	0.000992	0.00122	CcSEcCtD
Glycopyrrolate—Body temperature increased—Dexamethasone—multiple sclerosis	0.000992	0.00122	CcSEcCtD
Glycopyrrolate—Abdominal pain—Dexamethasone—multiple sclerosis	0.000992	0.00122	CcSEcCtD
Glycopyrrolate—Asthenia—Methylprednisolone—multiple sclerosis	0.00099	0.00121	CcSEcCtD
Glycopyrrolate—Insomnia—Prednisone—multiple sclerosis	0.000988	0.00121	CcSEcCtD
Glycopyrrolate—Pruritus—Triamcinolone—multiple sclerosis	0.000978	0.0012	CcSEcCtD
Glycopyrrolate—Pruritus—Methylprednisolone—multiple sclerosis	0.000976	0.0012	CcSEcCtD
Glycopyrrolate—Convulsion—Methotrexate—multiple sclerosis	0.000969	0.00119	CcSEcCtD
Glycopyrrolate—Dyspepsia—Prednisone—multiple sclerosis	0.000962	0.00118	CcSEcCtD
Glycopyrrolate—Rash—Prednisolone—multiple sclerosis	0.000948	0.00116	CcSEcCtD
Glycopyrrolate—Dermatitis—Prednisolone—multiple sclerosis	0.000947	0.00116	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000946	0.00116	CcSEcCtD
Glycopyrrolate—Fatigue—Prednisone—multiple sclerosis	0.000942	0.00115	CcSEcCtD
Glycopyrrolate—Headache—Prednisolone—multiple sclerosis	0.000942	0.00115	CcSEcCtD
Glycopyrrolate—Constipation—Prednisone—multiple sclerosis	0.000934	0.00115	CcSEcCtD
Glycopyrrolate—Confusional state—Methotrexate—multiple sclerosis	0.000921	0.00113	CcSEcCtD
Glycopyrrolate—Dizziness—Triamcinolone—multiple sclerosis	0.000914	0.00112	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000913	0.00112	CcSEcCtD
Glycopyrrolate—Dizziness—Methylprednisolone—multiple sclerosis	0.000912	0.00112	CcSEcCtD
Glycopyrrolate—Infection—Methotrexate—multiple sclerosis	0.000907	0.00111	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Prednisone—multiple sclerosis	0.0009	0.0011	CcSEcCtD
Glycopyrrolate—Asthenia—Dexamethasone—multiple sclerosis	0.0009	0.0011	CcSEcCtD
Glycopyrrolate—Asthenia—Betamethasone—multiple sclerosis	0.0009	0.0011	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Methotrexate—multiple sclerosis	0.000895	0.0011	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000893	0.0011	CcSEcCtD
Glycopyrrolate—Nausea—Prednisolone—multiple sclerosis	0.000893	0.00109	CcSEcCtD
Glycopyrrolate—Pruritus—Betamethasone—multiple sclerosis	0.000888	0.00109	CcSEcCtD
Glycopyrrolate—Pruritus—Dexamethasone—multiple sclerosis	0.000888	0.00109	CcSEcCtD
Glycopyrrolate—Skin disorder—Methotrexate—multiple sclerosis	0.000887	0.00109	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000883	0.00108	CcSEcCtD
Glycopyrrolate—Vomiting—Triamcinolone—multiple sclerosis	0.000879	0.00108	CcSEcCtD
Glycopyrrolate—Vomiting—Methylprednisolone—multiple sclerosis	0.000877	0.00108	CcSEcCtD
Glycopyrrolate—Rash—Triamcinolone—multiple sclerosis	0.000872	0.00107	CcSEcCtD
Glycopyrrolate—Dermatitis—Triamcinolone—multiple sclerosis	0.000871	0.00107	CcSEcCtD
Glycopyrrolate—Rash—Methylprednisolone—multiple sclerosis	0.00087	0.00107	CcSEcCtD
Glycopyrrolate—Dermatitis—Methylprednisolone—multiple sclerosis	0.000869	0.00107	CcSEcCtD
Glycopyrrolate—Urticaria—Prednisone—multiple sclerosis	0.000868	0.00106	CcSEcCtD
Glycopyrrolate—Headache—Triamcinolone—multiple sclerosis	0.000866	0.00106	CcSEcCtD
Glycopyrrolate—Headache—Methylprednisolone—multiple sclerosis	0.000864	0.00106	CcSEcCtD
Glycopyrrolate—Abdominal pain—Prednisone—multiple sclerosis	0.000864	0.00106	CcSEcCtD
Glycopyrrolate—Body temperature increased—Prednisone—multiple sclerosis	0.000864	0.00106	CcSEcCtD
Glycopyrrolate—Hypotension—Methotrexate—multiple sclerosis	0.000853	0.00105	CcSEcCtD
Glycopyrrolate—Dizziness—Betamethasone—multiple sclerosis	0.00083	0.00102	CcSEcCtD
Glycopyrrolate—Dizziness—Dexamethasone—multiple sclerosis	0.00083	0.00102	CcSEcCtD
Glycopyrrolate—Insomnia—Methotrexate—multiple sclerosis	0.000826	0.00101	CcSEcCtD
Glycopyrrolate—Nausea—Triamcinolone—multiple sclerosis	0.000821	0.00101	CcSEcCtD
Glycopyrrolate—Nausea—Methylprednisolone—multiple sclerosis	0.000819	0.001	CcSEcCtD
Glycopyrrolate—Somnolence—Methotrexate—multiple sclerosis	0.000812	0.000995	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Prednisone—multiple sclerosis	0.000805	0.000987	CcSEcCtD
Glycopyrrolate—Dyspepsia—Methotrexate—multiple sclerosis	0.000804	0.000985	CcSEcCtD
Glycopyrrolate—Vomiting—Betamethasone—multiple sclerosis	0.000798	0.000978	CcSEcCtD
Glycopyrrolate—Vomiting—Dexamethasone—multiple sclerosis	0.000798	0.000978	CcSEcCtD
Glycopyrrolate—Rash—Dexamethasone—multiple sclerosis	0.000791	0.00097	CcSEcCtD
Glycopyrrolate—Rash—Betamethasone—multiple sclerosis	0.000791	0.00097	CcSEcCtD
Glycopyrrolate—Dermatitis—Dexamethasone—multiple sclerosis	0.00079	0.000969	CcSEcCtD
Glycopyrrolate—Dermatitis—Betamethasone—multiple sclerosis	0.00079	0.000969	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000788	0.000966	CcSEcCtD
Glycopyrrolate—Fatigue—Methotrexate—multiple sclerosis	0.000787	0.000965	CcSEcCtD
Glycopyrrolate—Headache—Betamethasone—multiple sclerosis	0.000786	0.000964	CcSEcCtD
Glycopyrrolate—Headache—Dexamethasone—multiple sclerosis	0.000786	0.000964	CcSEcCtD
Glycopyrrolate—Asthenia—Prednisone—multiple sclerosis	0.000784	0.000961	CcSEcCtD
Glycopyrrolate—Pain—Methotrexate—multiple sclerosis	0.000781	0.000957	CcSEcCtD
Glycopyrrolate—Pruritus—Prednisone—multiple sclerosis	0.000773	0.000948	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Methotrexate—multiple sclerosis	0.000752	0.000922	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000747	0.000915	CcSEcCtD
Glycopyrrolate—Nausea—Dexamethasone—multiple sclerosis	0.000745	0.000914	CcSEcCtD
Glycopyrrolate—Nausea—Betamethasone—multiple sclerosis	0.000745	0.000914	CcSEcCtD
Glycopyrrolate—Urticaria—Methotrexate—multiple sclerosis	0.000725	0.000889	CcSEcCtD
Glycopyrrolate—Dizziness—Prednisone—multiple sclerosis	0.000722	0.000886	CcSEcCtD
Glycopyrrolate—Abdominal pain—Methotrexate—multiple sclerosis	0.000722	0.000885	CcSEcCtD
Glycopyrrolate—Body temperature increased—Methotrexate—multiple sclerosis	0.000722	0.000885	CcSEcCtD
Glycopyrrolate—Vomiting—Prednisone—multiple sclerosis	0.000695	0.000852	CcSEcCtD
Glycopyrrolate—Rash—Prednisone—multiple sclerosis	0.000689	0.000845	CcSEcCtD
Glycopyrrolate—Dermatitis—Prednisone—multiple sclerosis	0.000688	0.000844	CcSEcCtD
Glycopyrrolate—Headache—Prednisone—multiple sclerosis	0.000684	0.000839	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Methotrexate—multiple sclerosis	0.000673	0.000825	CcSEcCtD
Glycopyrrolate—Asthenia—Methotrexate—multiple sclerosis	0.000655	0.000803	CcSEcCtD
Glycopyrrolate—Nausea—Prednisone—multiple sclerosis	0.000649	0.000796	CcSEcCtD
Glycopyrrolate—Pruritus—Methotrexate—multiple sclerosis	0.000646	0.000792	CcSEcCtD
Glycopyrrolate—Dizziness—Methotrexate—multiple sclerosis	0.000604	0.00074	CcSEcCtD
Glycopyrrolate—Vomiting—Methotrexate—multiple sclerosis	0.000581	0.000712	CcSEcCtD
Glycopyrrolate—Rash—Methotrexate—multiple sclerosis	0.000576	0.000706	CcSEcCtD
Glycopyrrolate—Dermatitis—Methotrexate—multiple sclerosis	0.000575	0.000705	CcSEcCtD
Glycopyrrolate—Headache—Methotrexate—multiple sclerosis	0.000572	0.000701	CcSEcCtD
Glycopyrrolate—Nausea—Methotrexate—multiple sclerosis	0.000542	0.000665	CcSEcCtD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000171	0.000927	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CCL3—multiple sclerosis	0.000169	0.000917	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCL3—multiple sclerosis	0.000169	0.000915	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CCR2—multiple sclerosis	0.000168	0.000914	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CCR2—multiple sclerosis	0.000168	0.000911	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCL3—multiple sclerosis	0.000167	0.000906	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CCR2—multiple sclerosis	0.000166	0.000902	CbGpPWpGaD
Glycopyrrolate—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000164	0.000891	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000163	0.000883	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PTGER4—multiple sclerosis	0.000162	0.00088	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CCL5—multiple sclerosis	0.000162	0.00088	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—RGS1—multiple sclerosis	0.000162	0.000877	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—RGS1—multiple sclerosis	0.000161	0.000874	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—CCR5—multiple sclerosis	0.000161	0.000873	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PTGER4—multiple sclerosis	0.000161	0.000872	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—RGS1—multiple sclerosis	0.00016	0.000866	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000159	0.000861	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000157	0.000853	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CXCR3—multiple sclerosis	0.000157	0.00085	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000155	0.000843	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CCL5—multiple sclerosis	0.000155	0.000843	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CXCR3—multiple sclerosis	0.000155	0.000842	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CNR1—multiple sclerosis	0.000155	0.000841	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—CCR5—multiple sclerosis	0.000154	0.000836	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CNR1—multiple sclerosis	0.000153	0.000832	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—GPR65—multiple sclerosis	0.000153	0.000832	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CCR2—multiple sclerosis	0.000153	0.00083	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—GPR65—multiple sclerosis	0.000153	0.000829	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCR2—multiple sclerosis	0.000152	0.000827	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000152	0.000824	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	0.000151	0.000821	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	0.000151	0.000819	CbGpPWpGaD
Glycopyrrolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000151	0.000817	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—POMC—multiple sclerosis	0.00015	0.000814	CbGpPWpGaD
Glycopyrrolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.00015	0.000814	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—POMC—multiple sclerosis	0.00015	0.000812	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	0.000148	0.000804	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCL3—multiple sclerosis	0.000148	0.000804	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000148	0.000801	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—CCL2—multiple sclerosis	0.000147	0.000797	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—CCL2—multiple sclerosis	0.000146	0.000794	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CCR5—multiple sclerosis	0.000146	0.000793	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	0.000145	0.000786	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—IL2RA—multiple sclerosis	0.000144	0.000781	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PTGER4—multiple sclerosis	0.000143	0.000774	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCL3—multiple sclerosis	0.000142	0.00077	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CNR1—multiple sclerosis	0.000141	0.000766	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CNR1—multiple sclerosis	0.000141	0.000763	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PGR—multiple sclerosis	0.00014	0.000762	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCR1—multiple sclerosis	0.00014	0.000761	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CXCL13—multiple sclerosis	0.00014	0.000761	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CCR5—multiple sclerosis	0.00014	0.000759	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00014	0.000759	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCR1—multiple sclerosis	0.00014	0.000758	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CXCL13—multiple sclerosis	0.00014	0.000758	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000139	0.000757	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	0.000139	0.000756	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	0.000138	0.000751	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	0.000138	0.000751	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000138	0.000749	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—IL2RA—multiple sclerosis	0.000138	0.000748	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CXCR3—multiple sclerosis	0.000138	0.000747	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PTGER4—multiple sclerosis	0.000137	0.000741	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CD28—multiple sclerosis	0.000136	0.00074	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PGR—multiple sclerosis	0.000134	0.00073	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCR2—multiple sclerosis	0.000134	0.000727	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CXCR3—multiple sclerosis	0.000132	0.000716	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CD28—multiple sclerosis	0.000131	0.000709	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCR2—multiple sclerosis	0.000128	0.000696	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000127	0.000689	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CXCL10—multiple sclerosis	0.000127	0.000687	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—POMC—multiple sclerosis	0.000126	0.000682	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	0.000125	0.000681	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CNR1—multiple sclerosis	0.000124	0.000671	CbGpPWpGaD
Glycopyrrolate—CHRM1—Circadian rythm related genes—IL6—multiple sclerosis	0.000122	0.000662	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—POMC—multiple sclerosis	0.00012	0.000654	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CCL5—multiple sclerosis	0.00012	0.000654	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CCL5—multiple sclerosis	0.00012	0.000651	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	0.000119	0.000645	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CNR1—multiple sclerosis	0.000118	0.000642	CbGpPWpGaD
Glycopyrrolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000116	0.000627	CbGpPWpGaD
Glycopyrrolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000115	0.000625	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—POMC—multiple sclerosis	0.000114	0.00062	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—CCL2—multiple sclerosis	0.000112	0.000606	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CXCL10—multiple sclerosis	0.000111	0.000604	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—POMC—multiple sclerosis	0.000109	0.000593	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CCL5—multiple sclerosis	0.000109	0.000593	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCL5—multiple sclerosis	0.000109	0.000592	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000109	0.000589	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—CCR5—multiple sclerosis	0.000108	0.000587	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	0.000108	0.000586	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	0.000107	0.000581	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—CCL2—multiple sclerosis	0.000107	0.000581	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000107	0.00058	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CXCL10—multiple sclerosis	0.000107	0.000578	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000107	0.000578	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000106	0.000573	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—BCHE—multiple sclerosis	0.000105	0.000569	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—TYK2—multiple sclerosis	0.000101	0.000551	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCL3—multiple sclerosis	9.99e-05	0.000542	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCL3—multiple sclerosis	9.96e-05	0.00054	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	9.86e-05	0.000535	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CCR5—multiple sclerosis	9.85e-05	0.000535	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCR5—multiple sclerosis	9.82e-05	0.000533	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CD86—multiple sclerosis	9.73e-05	0.000528	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	9.73e-05	0.000528	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—TYK2—multiple sclerosis	9.72e-05	0.000527	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL2RA—multiple sclerosis	9.71e-05	0.000527	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL2RA—multiple sclerosis	9.68e-05	0.000525	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PTGER4—multiple sclerosis	9.61e-05	0.000522	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	9.59e-05	0.00052	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PTGER4—multiple sclerosis	9.58e-05	0.00052	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCL5—multiple sclerosis	9.58e-05	0.00052	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	9.49e-05	0.000515	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PGR—multiple sclerosis	9.47e-05	0.000514	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PGR—multiple sclerosis	9.44e-05	0.000512	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PGR—multiple sclerosis	9.35e-05	0.000507	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CD86—multiple sclerosis	9.32e-05	0.000506	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—IL2—multiple sclerosis	9.3e-05	0.000505	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CXCR3—multiple sclerosis	9.29e-05	0.000504	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CXCR3—multiple sclerosis	9.26e-05	0.000502	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CD28—multiple sclerosis	9.2e-05	0.000499	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCL5—multiple sclerosis	9.18e-05	0.000498	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CD28—multiple sclerosis	9.17e-05	0.000498	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	9.17e-05	0.000497	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CD28—multiple sclerosis	9.08e-05	0.000493	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCR2—multiple sclerosis	9.03e-05	0.00049	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCR2—multiple sclerosis	9e-05	0.000489	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	8.92e-05	0.000484	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—IL2—multiple sclerosis	8.9e-05	0.000483	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—SPP1—multiple sclerosis	8.87e-05	0.000482	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCR5—multiple sclerosis	8.63e-05	0.000468	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL2RA—multiple sclerosis	8.51e-05	0.000462	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—SPP1—multiple sclerosis	8.5e-05	0.000461	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—POMC—multiple sclerosis	8.48e-05	0.00046	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—POMC—multiple sclerosis	8.45e-05	0.000459	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—IL2—multiple sclerosis	8.44e-05	0.000458	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	8.37e-05	0.000454	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CNR1—multiple sclerosis	8.34e-05	0.000452	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CNR1—multiple sclerosis	8.31e-05	0.000451	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCR5—multiple sclerosis	8.27e-05	0.000449	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	8.23e-05	0.000447	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL2RA—multiple sclerosis	8.15e-05	0.000442	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—IL2—multiple sclerosis	8.09e-05	0.000439	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—APOE—multiple sclerosis	7.85e-05	0.000426	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—POMC—multiple sclerosis	7.7e-05	0.000418	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—POMC—multiple sclerosis	7.68e-05	0.000417	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	7.6e-05	0.000412	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—CCL2—multiple sclerosis	7.54e-05	0.000409	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—APOE—multiple sclerosis	7.52e-05	0.000408	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—CCL2—multiple sclerosis	7.51e-05	0.000408	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CXCL10—multiple sclerosis	7.51e-05	0.000407	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CXCL10—multiple sclerosis	7.48e-05	0.000406	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	7.44e-05	0.000404	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	7.41e-05	0.000402	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CD80—multiple sclerosis	7.1e-05	0.000385	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—TYK2—multiple sclerosis	6.84e-05	0.000371	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—TYK2—multiple sclerosis	6.82e-05	0.00037	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CD80—multiple sclerosis	6.8e-05	0.000369	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	6.75e-05	0.000366	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—POMC—multiple sclerosis	6.75e-05	0.000366	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CCL2—multiple sclerosis	6.6e-05	0.000358	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CD86—multiple sclerosis	6.56e-05	0.000356	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CD86—multiple sclerosis	6.54e-05	0.000355	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CD86—multiple sclerosis	6.48e-05	0.000352	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCL5—multiple sclerosis	6.46e-05	0.000351	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—POMC—multiple sclerosis	6.46e-05	0.000351	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—MAPK1—multiple sclerosis	6.46e-05	0.00035	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCL5—multiple sclerosis	6.44e-05	0.000349	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	6.38e-05	0.000346	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CCL2—multiple sclerosis	6.32e-05	0.000343	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—APOE—multiple sclerosis	6.31e-05	0.000343	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—IL2—multiple sclerosis	6.27e-05	0.00034	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—IL2—multiple sclerosis	6.25e-05	0.000339	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	6.19e-05	0.000336	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—MAPK1—multiple sclerosis	6.19e-05	0.000336	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TYK2—multiple sclerosis	5.99e-05	0.000325	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SPP1—multiple sclerosis	5.98e-05	0.000325	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SPP1—multiple sclerosis	5.96e-05	0.000324	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	5.91e-05	0.000321	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCR5—multiple sclerosis	5.82e-05	0.000316	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCR5—multiple sclerosis	5.8e-05	0.000315	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	5.75e-05	0.000312	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TYK2—multiple sclerosis	5.74e-05	0.000311	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	5.74e-05	0.000311	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL2RA—multiple sclerosis	5.72e-05	0.00031	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	5.69e-05	0.000309	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL2—multiple sclerosis	5.68e-05	0.000308	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	5.66e-05	0.000307	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	5.62e-05	0.000305	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—POMC—multiple sclerosis	5.42e-05	0.000294	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—APOE—multiple sclerosis	5.3e-05	0.000287	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—APOE—multiple sclerosis	5.28e-05	0.000286	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—APOE—multiple sclerosis	5.23e-05	0.000284	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL2—multiple sclerosis	4.99e-05	0.000271	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—IL6—multiple sclerosis	4.96e-05	0.000269	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ALB—multiple sclerosis	4.94e-05	0.000268	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CD80—multiple sclerosis	4.79e-05	0.00026	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL2—multiple sclerosis	4.78e-05	0.000259	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CD80—multiple sclerosis	4.77e-05	0.000259	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—IL6—multiple sclerosis	4.75e-05	0.000258	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CD80—multiple sclerosis	4.73e-05	0.000256	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MMP9—multiple sclerosis	4.72e-05	0.000256	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—POMC—multiple sclerosis	4.55e-05	0.000247	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—POMC—multiple sclerosis	4.53e-05	0.000246	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MMP9—multiple sclerosis	4.52e-05	0.000245	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—POMC—multiple sclerosis	4.49e-05	0.000244	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	4.45e-05	0.000242	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	4.44e-05	0.000241	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	4.39e-05	0.000238	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	4.36e-05	0.000236	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	4.34e-05	0.000236	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	4.3e-05	0.000233	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—STAT3—multiple sclerosis	4.2e-05	0.000228	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	4.04e-05	0.000219	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	4.03e-05	0.000219	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—STAT3—multiple sclerosis	4.02e-05	0.000218	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	3.99e-05	0.000216	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MYC—multiple sclerosis	3.9e-05	0.000212	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TGFB1—multiple sclerosis	3.89e-05	0.000211	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MAPK1—multiple sclerosis	3.82e-05	0.000207	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MYC—multiple sclerosis	3.74e-05	0.000203	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TGFB1—multiple sclerosis	3.73e-05	0.000202	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MAPK1—multiple sclerosis	3.65e-05	0.000198	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL2—multiple sclerosis	3.36e-05	0.000182	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL2—multiple sclerosis	3.35e-05	0.000182	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	3.35e-05	0.000182	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	3.34e-05	0.000181	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL2—multiple sclerosis	3.32e-05	0.00018	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	3.3e-05	0.000179	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	3.18e-05	0.000173	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	3.17e-05	0.000172	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	3.14e-05	0.00017	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—IL6—multiple sclerosis	2.93e-05	0.000159	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	2.83e-05	0.000154	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	2.82e-05	0.000153	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—IL6—multiple sclerosis	2.81e-05	0.000152	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	2.79e-05	0.000152	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MYC—multiple sclerosis	2.63e-05	0.000143	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	2.62e-05	0.000142	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MYC—multiple sclerosis	2.62e-05	0.000142	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	2.62e-05	0.000142	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MYC—multiple sclerosis	2.6e-05	0.000141	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	2.59e-05	0.000141	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	2.57e-05	0.00014	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	2.56e-05	0.000139	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	2.54e-05	0.000138	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—IL6—multiple sclerosis	1.98e-05	0.000107	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—IL6—multiple sclerosis	1.97e-05	0.000107	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—IL6—multiple sclerosis	1.95e-05	0.000106	CbGpPWpGaD
